Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05840081 · ClinicalTrials.gov registry record · NA
Dairy Fat and Fermentation Study
A NA study of Inflammation and Heart Diseases, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT05840081: Completed NA study of Inflammation and Heart Diseases, sponsored by Tufts University.
NCT05840081 is a NA study of Inflammation and Heart Diseases that has completed, run by Tufts University. The registered enrollment target is 37 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05840081, a NA study of Inflammation and Heart Diseases, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare the effect of consuming full-fat (regular) and fat-free (skim) milk, as well as full-fat and fat-free yogurt (a fermented dairy product), on microorganisms in your gut as well as the products produced by the gut microbes. We will also determine whether consuming these dairy products affects risk factors for heart disease.The findings of the study will help us determine if heart disease risk factors are modified by the fat content and fermentation of milk. The results may facilitate refinement of public health dietary guidance for cardiovascular disease risk reduction.
Primary Outcome
Determine the effects of dairy fat in milk, with and without fermentation, on gut microbiome
Conditions Studied
Interventions
- OTHER Milk or yogurt beverage
Study Locations (1)
Massachusetts
- Jean Mayer Human Nutrition Research Center on Aging - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2025-08-19 |
| Phase | NA |
What the finished NCT05840081 record still lists
NCT05840081 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Milk or yogurt beverage is the first listed.
NCT05840081 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05840081 about?
NCT05840081 is a clinical study titled "Dairy Fat and Fermentation Study". The purpose of the study is to compare the effect of consuming full-fat (regular) and fat-free (skim) milk, as well as full-fat and fat-free yogurt (a fermented dairy product), on microorganisms in your gut as well as the products produced by the gut microbes. We will also determine whether consumin...
What is the current status of trial NCT05840081?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2023-10-01. Estimated completion is 2025-08-19.
What conditions does trial NCT05840081 study?
This clinical trial studies the following conditions: Inflammation, Heart Diseases, Microbial Colonization.
What interventions are being tested in trial NCT05840081?
The interventions under investigation include: Milk or yogurt beverage (OTHER).
Who is sponsoring clinical trial NCT05840081?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05840081 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05840081's enrollment target sits among peer trials
37 89th of 132 higher than 43 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.
RECRUITING · NA
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI